Related Experiment Video
Updated: May 7, 2026

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk
Hansong Wang1, Darin Taverna, Daniel O Stram
1Authors' Affiliations: University of Hawaii Cancer Center, Honolulu, Hawaii; Translational Genomics Research Institute, Phoenix, Arizona; Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles; Cancer Prevention Institute of California, Fremont, California; Fred Hutchinson Cancer Research Center, Seattle, Washington; Mayo Clinic, Rochester, Minnesota; University of Melbourne, Carlton, Victoria, Australia; Cancer Care Ontario, Toronto, Ontario, Canada; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina; Stanford Cancer Institute, Stanford, California; and National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.
Background:
It is widely accepted that chronic inflammation plays a role in the etiology of colorectal cancer. Using a two-stage design, we examined the associations between colorectal cancer and common variation in 37 key genes in the inflammation and innate immunity pathways.
Methods:
In the discovery stage, 2,322 discordant sibships (2,535 cases, 3,915 sibling controls) from the Colorectal Cancer Family Registry were genotyped for more than 600 tagSNPs and 99 single-nucleotide polymorphisms (SNP) were selected for further examination based on strength of association. In the second stage, 351 SNPs tagging gene regions covered by the 99 SNPs were tested in 4,783 Multiethnic Cohort subjects (2,153 cases, 2,630 controls).
Results:
The association between rs9858822 in the PPARG gene and colorectal cancer was statistically significant at the end of the second stage (OR per allele = 1.36, Bonferroni-adjusted P = 0.045), based on the "effective" number of markers in stage II (n = 306). The risk allele C was common (frequency 0.3) in African Americans but rare (frequency < 0.03) in whites, Japanese Americans, Latinos, and Native Hawaiians. No statistically significant heterogeneity of effects across race/ethnicity, body mass index (BMI) levels, regular aspirin use, or pack-years of smoking was detected for this SNP. Suggestive associations were also observed for several SNPs in close vicinity to rs9858822.
Conclusions:
Our results provide new evidence of association between PPARG variants and colorectal cancer risk.
Impact:
Further replication in independent samples is warranted.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Cancer Prevention
Some...
Principles of Pharmacogenetics: Types of Genetic Variants
